Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
55
LMAT Quote, Financials, Valuation and Earnings
Last price:
$108.28
Seasonality move
:
3.92%
Day range:
$105.85 - $112.74
52-week range:
$71.42 - $115.33
Dividend yield:
0.74%
P/E ratio:
43.01x
P/S ratio:
10.09x
P/B ratio:
6.48x
Volume:
508.5K
Avg. volume:
191.5K
1-year change:
8.28%
Market cap:
$2.5B
Revenue:
$249.6M
EPS (TTM):
$2.52
Analysts' Opinion
-
Consensus RatingLeMaitre Vascular, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $109.22, LeMaitre Vascular, Inc. has an estimated upside of 0.96% from its current price of $108.18.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $94.00 representing 13.11% downside risk from its current price of $108.18.
Fair Value
-
According to the consensus of 9 analysts, LeMaitre Vascular, Inc. has 0.96% upside to fair value with a price target of $109.22 per share.
LMAT vs. S&P 500
-
Over the past 5 trading days, LeMaitre Vascular, Inc. has overperformed the S&P 500 by 16.92% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
LeMaitre Vascular, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
LeMaitre Vascular, Inc. has grown year-over-year revenues for 22 quarters straight. In the most recent quarter LeMaitre Vascular, Inc. reported revenues of $64.5M.
Earnings Growth
-
LeMaitre Vascular, Inc. has grown year-over-year earnings for 11 quarters straight. In the most recent quarter LeMaitre Vascular, Inc. reported earnings per share of $0.68.
Enterprise value:
2.3B
EV / Invested capital:
3.94x
Price / LTM sales:
10.09x
EV / EBIT:
33.58x
EV / Revenue:
9.14x
PEG ratio (5yr expected):
1.43x
EV / Free cash flow:
34.44x
Price / Operating cash flow:
32.11x
Enterprise value / EBITDA:
29.12x
Gross Profit (TTM):
$174.2M
Return On Assets:
9.96%
Net Income Margin (TTM):
23.13%
Return On Equity:
15.86%
Return On Invested Capital:
10.5%
Operating Margin:
29.22%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $193.5M | $219.9M | $249.6M | $55.7M | $64.5M | |
| Gross Profit | $121M | $146.5M | $174.2M | $38.6M | $46.2M | |
| Operating Income | $37.2M | $52.3M | $67.9M | $12.9M | $18.8M | |
| EBITDA | $46.7M | $62M | $78.3M | $15.3M | $21.4M | |
| Diluted EPS | $1.34 | $1.93 | $2.52 | $0.49 | $0.68 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $134.4M | $156.7M | $188.9M | $393.2M | $468.2M | |
| Total Assets | $292.8M | $310.5M | $346.8M | $551.8M | $615.7M | |
| Current Liabilities | $21.8M | $25.3M | $29.9M | $30.6M | $36.3M | |
| Total Liabilities | $38.7M | $42.3M | $48.9M | $214.5M | $222.2M | |
| Total Equity | $254.2M | $268.2M | $297.9M | $337.3M | $393.5M | |
| Total Debt | $14.1M | $14.7M | $16.6M | $183M | $185.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $30.1M | $39.7M | $73.3M | $14.2M | $28.8M | |
| Cash From Investing | -$22.9M | -$28.5M | -$222M | -$12.9M | -$27.4M | |
| Cash From Financing | -$6.6M | -$8.7M | $153.1M | -$3.1M | -$3M | |
| Free Cash Flow | $22.8M | $33.5M | $66.2M | $12.6M | $26.5M | |
LMAT
Sector
Market Cap
$2.5B
$25.5M
Price % of 52-Week High
93.8%
50%
Dividend Yield
0.74%
0%
Shareholder Yield
-1.09%
-1.62%
1-Year Price Total Return
8.28%
-18.12%
Beta (5-Year)
0.719
0.496
Dividend yield:
0.74%
Annualized payout:
$0.80
Payout ratio:
29.41%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$96.35
200-day SMA
Buy
Level
$86.89
Bollinger Bands (100)
Buy
Level
82.44 - 91.04
Chaikin Money Flow
Buy
Level
22.4M
20-day SMA
Buy
Level
$90.83
Relative Strength Index (RSI14)
Buy
Level
73.66
ADX Line
Buy
Level
23.11
Williams %R
Neutral
Level
-23.8771
50-day SMA
Buy
Level
$86.96
MACD (12, 26)
Buy
Level
4.35
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
21.5M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (6.9999)
Buy
CA Score
(Annual)
Level (0.8051)
Buy
Beneish M-Score
(Annual)
Level (-3.1031)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.963)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.
Stock Forecast FAQ
In the current month, LMAT has received 4 Buy ratings 5 Hold ratings, and 0 Sell ratings. The LMAT average analyst price target in the past 3 months is $109.22.
-
Where Will LeMaitre Vascular, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that LeMaitre Vascular, Inc. share price will rise to $109.22 per share over the next 12 months.
-
What Do Analysts Say About LeMaitre Vascular, Inc.?
Analysts are divided on their view about LeMaitre Vascular, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that LeMaitre Vascular, Inc. is a Sell and believe this share price will drop from its current level to $94.00.
-
What Is LeMaitre Vascular, Inc.'s Price Target?
The price target for LeMaitre Vascular, Inc. over the next 1-year time period is forecast to be $109.22 according to 9 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is LMAT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for LeMaitre Vascular, Inc. is a Hold. 5 of 9 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of LMAT?
You can purchase shares of LeMaitre Vascular, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase LeMaitre Vascular, Inc. shares.
-
What Is The LeMaitre Vascular, Inc. Share Price Today?
LeMaitre Vascular, Inc. was last trading at $108.28 per share. This represents the most recent stock quote for LeMaitre Vascular, Inc.. Yesterday, LeMaitre Vascular, Inc. closed at $108.18 per share.
-
How To Buy LeMaitre Vascular, Inc. Stock Online?
In order to purchase LeMaitre Vascular, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get LMAT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LMAT
Sector
P/E ratio
43.01x
23.46x
PEG ratio
1.43x
-0.01x
P/B ratio
6.48x
1.81x
Price / LTM sales
10.09x
1.54x
Growth Metrics
LMAT
Sector
Revenue growth
15.68%
3.27%
Earnings growth
39.26%
11.11%
Revenue (5-year growth)
14.05%
6.38%
Earnings forecast
$0.66
-$0.19
Profitability
LMAT
Sector
Profitability FY 2025
$178.5M
$2.3M
Return on invested capital
10.5%
-33.25%
Return on assets
9.96%
-29.68%
Return on equity
15.86%
-39.33%
Earnings Date
Last Earnings Date
Feb
25
Next Earnings Date
May
7
Estimated Next Earnings Date
May
27
Balance Sheet
LMAT
Sector
Total cash
$359.1M
$24.1M
Short term investments
$274.1M
$23.8M
Total assets
$615.7M
$70.6M
Long term debt
$185.6M
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
54
AAOI alert for Feb 28
Applied Optoelectronics, Inc. [AAOI] is up 56.96% over the past day.
Buy
90
BNAI alert for Feb 28
Brand Engagement Network, Inc. [BNAI] is up 36.02% over the past day.
Sell
36
WLDN alert for Feb 28
Willdan Group, Inc. [WLDN] is down 25.56% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
